Anpario (LON:ANP) Share Price Passes Below 200 Day Moving Average – Here’s Why

Anpario plc (LON:ANPGet Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 495.14 and traded as low as GBX 490. Anpario shares last traded at GBX 514, with a volume of 16,855 shares trading hands.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research note on Monday, January 19th. Canaccord Genuity Group upgraded shares of Anpario to a “buy” rating and upped their price target for the company from GBX 457 to GBX 570 in a report on Thursday, April 2nd. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of GBX 570.

View Our Latest Analysis on Anpario

Anpario Price Performance

The stock has a market capitalization of £87.10 million, a price-to-earnings ratio of 13.55 and a beta of 0.92. The company has a quick ratio of 5.16, a current ratio of 4.50 and a debt-to-equity ratio of 0.60. The business’s 50 day simple moving average is GBX 496.17 and its 200-day simple moving average is GBX 495.04.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Articles

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.